SCHEMBL16338804

SCHEMBL16338804

CN(C)c1nc2ccccc2c2c(=O)c3cc(Cl)ccc3sc12

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.49
TOP1 P11387 1/20 0.48
TOP2A P11388 1/20 0.48
MAT2A P31153 2/20 0.42
PRMT5 O14744 1/20 0.42
PIM1 P11309 6/20 0.42
PIM2 Q9P1W9 5/20 0.42
KDM1A O60341 1/20 0.39
PDE10A Q9Y233 2/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
FABP3 P05413 1/20 0.36
CYP2C9 P11712 1/20 0.36
FABP4 P15090 1/20 0.36
FABP5 Q01469 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30163600 1.00 KDM4E (0.49) KDM4ETOP1TOP2AMAT2APRMT5
SCHEMBL17144042 0.92 TOP1 (0.43) KDM4ETOP1TOP2AMAT2APRMT5
SCHEMBL17655673 0.84 KDM4E (0.58) KDM4ETOP1TOP2APIM1PIM2
SCHEMBL17655671 0.82 KDM4E (0.52) KDM4ETOP1TOP2APIM1PIM2
SCHEMBL16339120 0.82 KDM4E (0.52) KDM4ETOP1TOP2APIM1PIM2
SCHEMBL30163607 0.81 KDM4E (0.49) KDM4ETOP1TOP2AMAT2APIM1
SCHEMBL16339385 0.81 KDM4E (0.49) KDM4ETOP1TOP2AMAT2APIM1
SCHEMBL16338785 0.81 KDM4E (0.49) KDM4ETOP1TOP2AMAT2APIM1
SCHEMBL21451040 0.79 TOP1 (0.41) KDM4ETOP1TOP2AKDM1ALMNA
SCHEMBL16339164 0.79 MAT2A (0.47) KDM4ETOP1TOP2AMAT2APIM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3002287-B1 Thiochromeno[2,3-c]quinolin-12-one derivatives and their use as topoisomerase inhibitors NAT DEFENSE MEDICAL CENTER (TW) 2018-01-31 EP claimed
EP-3002287-A1 Thiochromeno[2,3-c]quinolin-12-one derivatives and their use as topoisomerase inhibitors National Defense Medical Center (TW) 2016-04-06 EP claimed
US-8927717-B1 Thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2015-01-06 US claimed
CN-106659765-B Use of dianhydrogalactitol and analogs or derivatives thereof for treating non-small cell lung cancer and ovarian cancer 德玛医药 2021-08-13 CN disclosed
EP-3002287-B1 Thiochromeno[2,3-c]quinolin-12-one derivatives and their use as topoisomerase inhibitors NAT DEFENSE MEDICAL CENTER (TW) 2018-01-31 EP disclosed
EP-3002287-A1 Thiochromeno[2,3-c]quinolin-12-one derivatives and their use as topoisomerase inhibitors National Defense Medical Center (TW) 2016-04-06 EP disclosed
US-8927717-B1 Thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof NATIONAL DEFENSE MEDICAL CENTER (TW) 2015-01-06 US disclosed